KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Asset Utilization Ratio data on record, last reported at 0.27 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 49.51% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, down 49.51%, while the annual FY2025 figure was 0.34, 53.06% down from the prior year.
  • Asset Utilization Ratio reached 0.27 in Q4 2025 per AQST's latest filing, down from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.87 in Q4 2023 and bottomed at 0.27 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.55, with a median of 0.54 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: crashed 51.81% in 2021, then skyrocketed 98.46% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2021, then surged by 137.09% to 0.78 in 2022, then grew by 11.14% to 0.87 in 2023, then crashed by 37.09% to 0.54 in 2024, then tumbled by 49.51% to 0.27 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.27 in Q4 2025, 0.34 in Q3 2025, and 0.45 in Q2 2025.